Dan Quinn co-founded Ten Bridge Communications with more than 20 years of experience in building leading corporate brands in healthcare. Previously, as managing director of Feinstein Kean Healthcare, Dan led brand strategy and corporate communications activities for biotech and pharma clients, helping to create, launch and promote companies of all sizes, from emerging biotechnology to the world's largest pharmaceutical and consumer products organizations. Previously, Dan spent nearly seven years at Genzyme Corporation where he worked to protect and enhance the company's global reputation through financial, product, employee, and crisis communications. He helped to steer communications strategy through the approval and launch of four new orphan therapies, more than a dozen acquisitions, and multiple crises and regulatory milestones. Prior to Genzyme, Dan led communications for the National Academy of Sciences' Institute of Medicine, engaging with media, Congress, government agencies and advocacy interests to launch dozens of high-profile health policy reports each year. He has also worked to promote the work of the medical and nutrition faculty at Tufts University, and began his career as a journalist in Massachusetts.